89bio, Inc. Retained Earnings
89bio, Inc. had Retained Earnings of -$1.01 billion as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-08-08
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$1.01B.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$895.79M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$824.51M.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$706.16M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-06-30 | -$1.01B 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$895.79M 10-Q · filed 2025-05-02 |
| 2024-12-31 | -$824.51M 10-Q · filed 2025-08-08 |
| 2024-09-30 | -$706.16M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$557.08M 10-Q · filed 2024-08-05 |
| 2024-03-31 | -$509.11M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$457.43M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$417.20M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$382.47M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$344.08M 10-Q · filed 2023-05-08 |
| 2022-12-31 | -$315.24M 10-K · filed 2024-03-01 |
| 2022-09-30 | -$290.64M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$263.84M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$238.78M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$213.22M 10-K · filed 2023-03-15 |
| 2021-09-30 | -$186.93M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$158.60M 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$137.88M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$123.09M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$110.51M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$95.91M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$84.14M 10-Q · filed 2020-05-13 |
| 2019-12-31 | -$73.60M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$54.31M 10-Q · filed 2019-12-18 |
| 2018-12-31 | -$16.18M 10-K · filed 2020-03-18 |